These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Application of artificial enzymes to the problem of cocaine. De Prada P; Winger G; Landry DW Ann N Y Acad Sci; 2000; 909():159-69. PubMed ID: 10911929 [TBL] [Abstract][Full Text] [Related]
3. Antibody-catalyzed degradation of cocaine. Landry DW; Zhao K; Yang GX; Glickman M; Georgiadis TM Science; 1993 Mar; 259(5103):1899-901. PubMed ID: 8456315 [TBL] [Abstract][Full Text] [Related]
4. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. Mets B; Winger G; Cabrera C; Seo S; Jamdar S; Yang G; Zhao K; Briscoe RJ; Almonte R; Woods JH; Landry DW Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10176-81. PubMed ID: 9707620 [TBL] [Abstract][Full Text] [Related]
5. Cocaine catalytic antibodies: the primary importance of linker effects. Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477 [TBL] [Abstract][Full Text] [Related]
6. Anti-cocaine catalytic antibodies--a novel approach to the problem of addiction. Landry DW; Yang GX J Addict Dis; 1997; 16(3):1-17. PubMed ID: 9243335 [TBL] [Abstract][Full Text] [Related]
7. Enzyme may blunt cocaine's action. Morell V Science; 1993 Mar; 259(5103):1828. PubMed ID: 8456310 [No Abstract] [Full Text] [Related]
8. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment. Kuhar MJ; Carroll FI; Bharat N; Landry DW Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, properties, and reactivity of cocaine benzoylthio ester possessing the cocaine absolute configuration. Isomura S; Hoffman TZ; Wirsching P; Janda KD J Am Chem Soc; 2002 Apr; 124(14):3661-8. PubMed ID: 11929256 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of single chain anti-cocaine catalytic antibodies. McKenzie KM; Mee JM; Rogers CJ; Hixon MS; Kaufmann GF; Janda KD J Mol Biol; 2007 Jan; 365(3):722-31. PubMed ID: 17084858 [TBL] [Abstract][Full Text] [Related]
12. Structure-and-mechanism-based design and discovery of therapeutics for cocaine overdose and addiction. Zheng F; Zhan CG Org Biomol Chem; 2008 Mar; 6(5):836-43. PubMed ID: 18292872 [TBL] [Abstract][Full Text] [Related]
13. Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies. Schabacker DS; Kirschbaum KS; Segre M Immunology; 2000 May; 100(1):48-56. PubMed ID: 10809958 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose. Carrera MR; Trigo JM; Wirsching P; Roberts AJ; Janda KD Pharmacol Biochem Behav; 2005 Aug; 81(4):709-14. PubMed ID: 16005948 [TBL] [Abstract][Full Text] [Related]
15. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. Cashman JR; Berkman CE; Underiner GE J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397 [TBL] [Abstract][Full Text] [Related]
16. The future potential for cocaine vaccines. Orson FM; Wang R; Brimijoin S; Kinsey BM; Singh RA; Ramakrishnan M; Wang HY; Kosten TR Expert Opin Biol Ther; 2014 Sep; 14(9):1271-83. PubMed ID: 24835496 [TBL] [Abstract][Full Text] [Related]
17. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. Baird TJ; Deng SX; Landry DW; Winger G; Woods JH J Pharmacol Exp Ther; 2000 Dec; 295(3):1127-34. PubMed ID: 11082449 [TBL] [Abstract][Full Text] [Related]
18. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination. Wenthur CJ; Cai X; Ellis BA; Janda KD Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828 [TBL] [Abstract][Full Text] [Related]